Clinical Trials
45 trialsREVEAL
Ono Pharmaceutical Co., Ltd.
RITUXIMAB BS Intravenous Infusion 100mgăť500mg [Pfizer] Post-marketing Database Study
Pfizer
OPAL
Janssen Biotech, Inc.
realMIND
Incyte Corporation
LTFS
Caribou Biosciences, Inc.
CAMPERR
Adela, Inc
A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
Takeda
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
HOPE
Ossium Health, Inc.
RevlimidÂŽ Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)
Celgene
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL
AstraZeneca
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
RevlimidÂŽ Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab
Bristol-Myers Squibb
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Strata Oncology
BELUGA
Munich Leukemia Laboratory
SIRIUS
Munich Leukemia Laboratory
REALM
Takeda
QUANTUM
VitaMed Research LLC
CREDIT
Takeda
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
Kyowa Kirin Co., Ltd.
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
ORHEO
Hospira, now a wholly owned subsidiary of Pfizer
Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric⢠Flow Cytometer
Becton, Dickinson and Company
Navigating the Clinical Research Process for Lymphoma
Power Life Sciences Inc.
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
(ANSWer)
Notable Labs
REAL
SecuraBio
An Observational Study of Patients With Malignant Lymphomas Treated With MabTheraÂŽ SC in Everyday Clinical Practice
Hoffmann-La Roche
Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)
Amgen
Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma
Agios Pharmaceuticals, Inc.
COMPLETE
Acrotech Biopharma Inc.
PREDICARE
LEO Pharma
CGMs
Hamad Medical Corporation
Biosimilar Retacrit⢠(Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
Hospira, now a wholly owned subsidiary of Pfizer
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor
Sanofi
HOLA
Janssen-Cilag Ltd.
MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
Hoffmann-La Roche
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
Sanofi
Registry of Patients Treated With Plerixafor (MozobilÂŽ) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation
Sanofi
An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.
Centocor Ortho Biotech Services, L.L.C.
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
novoGI
RETROPRESS
novoGI
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Wyeth is now a wholly owned subsidiary of Pfizer